386 related articles for article (PubMed ID: 10357972)
1. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men.
Liu PY; Turner L; Rushford D; McDonald J; Baker HW; Conway AJ; Handelsman DJ
Hum Reprod; 1999 Jun; 14(6):1540-5. PubMed ID: 10357972
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.
Bergh C; Howles CM; Borg K; Hamberger L; Josefsson B; Nilsson L; Wikland M
Hum Reprod; 1997 Oct; 12(10):2133-9. PubMed ID: 9402268
[TBL] [Abstract][Full Text] [Related]
3. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men.
Liu PY; Gebski VJ; Turner L; Conway AJ; Wishart SM; Handelsman DJ
Hum Reprod; 2002 Mar; 17(3):625-33. PubMed ID: 11870114
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists.
Frydman R; Howles CM; Truong F
Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190
[TBL] [Abstract][Full Text] [Related]
5. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome.
Raivio T; Wikström AM; Dunkel L
Eur J Endocrinol; 2007 Jan; 156(1):105-11. PubMed ID: 17218732
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism.
Burgués S; Calderón MD
Hum Reprod; 1997 May; 12(5):980-6. PubMed ID: 9194651
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male.
Kliesch S; Behre HM; Nieschlag E
Fertil Steril; 1995 Jun; 63(6):1326-8. PubMed ID: 7750608
[TBL] [Abstract][Full Text] [Related]
8. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM
Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
[TBL] [Abstract][Full Text] [Related]
9. Testicular function in a birth cohort of young men.
Hart RJ; Doherty DA; McLachlan RI; Walls ML; Keelan JA; Dickinson JE; Skakkebaek NE; Norman RJ; Handelsman DJ
Hum Reprod; 2015 Dec; 30(12):2713-24. PubMed ID: 26409015
[TBL] [Abstract][Full Text] [Related]
10. Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non-obstructive azoospermia.
Shiraishi K; Ohmi C; Shimabukuro T; Matsuyama H
Hum Reprod; 2012 Feb; 27(2):331-9. PubMed ID: 22128297
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin HP Study Group.
Fertil Steril; 1998 Aug; 70(2):256-62. PubMed ID: 9696217
[TBL] [Abstract][Full Text] [Related]
12. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.
Matsumoto AM; Karpas AE; Paulsen CA; Bremner WJ
J Clin Invest; 1983 Sep; 72(3):1005-15. PubMed ID: 6411766
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism.
Bouloux P; Warne DW; Loumaye E;
Fertil Steril; 2002 Feb; 77(2):270-3. PubMed ID: 11821082
[TBL] [Abstract][Full Text] [Related]
14. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone.
Bouloux PM; Nieschlag E; Burger HG; Skakkebaek NE; Wu FC; Handelsman DJ; Baker GH; Ochsenkuehn R; Syska A; McLachlan RI; Giwercman A; Conway AJ; Turner L; van Kuijk JH; Voortman G
J Androl; 2003; 24(4):604-11. PubMed ID: 12826700
[TBL] [Abstract][Full Text] [Related]
15. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
Matsumoto AM; Karpas AE; Bremner WJ
J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism.
Finkel DM; Phillips JL; Snyder PJ
N Engl J Med; 1985 Sep; 313(11):651-5. PubMed ID: 3927163
[TBL] [Abstract][Full Text] [Related]
17. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
18. Endocrinology of male infertility.
de Kretser DM
Br Med Bull; 1979 May; 35(2):187-92. PubMed ID: 387166
[TBL] [Abstract][Full Text] [Related]
19. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism.
Sinisi AA; Esposito D; Bellastella G; Maione L; Palumbo V; Gandini L; Lombardo F; De Bellis A; Lenzi A; Bellastella A
J Endocrinol Invest; 2010 Oct; 33(9):618-23. PubMed ID: 20436264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
